Albert David [ALBERTDAVD] vs Sequent Scientific [SEQUENT] Detailed Stock Comparison
Albert David
NSE
Loading...
Sequent Scientific
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Albert David wins in 12 metrics, Sequent Scientific wins in 5 metrics, with 0 ties. Albert David appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Albert David | Sequent Scientific | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 26.89 | 210.48 | Albert David |
| Price-to-Book Ratio | 1.18 | 6.35 | Albert David |
| Debt-to-Equity Ratio | 3.14 | 62.47 | Albert David |
| PEG Ratio | N/A | 35.43 | N/A |
| EV/EBITDA | -23.37 | 30.33 | Albert David |
| Profit Margin (TTM) | 1.93% | 1.41% | Albert David |
| Operating Margin (TTM) | -18.48% | 9.41% | Sequent Scientific |
| EBITDA Margin (TTM) | N/A | 9.41% | N/A |
| Return on Equity | 4.38% | 4.35% | Albert David |
| Return on Assets (TTM) | 3.36% | 4.01% | Sequent Scientific |
| Free Cash Flow (TTM) | $-432.92M | $442.70M | Sequent Scientific |
| Dividend Yield | 1.86% | N/A | N/A |
| 1-Year Return | -36.97% | 22.29% | Sequent Scientific |
| Price-to-Sales Ratio (TTM) | 1.42 | 2.89 | Albert David |
| Enterprise Value | $2.30B | $48.00B | Sequent Scientific |
| EV/Revenue Ratio | 0.70 | 3.09 | Albert David |
| Gross Profit Margin (TTM) | 60.84% | 50.28% | Albert David |
| Revenue per Share (TTM) | $573 | $62 | Albert David |
| Earnings per Share (Diluted) | $30.17 | $0.85 | Albert David |
| Beta (Stock Volatility) | 0.07 | 0.91 | Albert David |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Albert David vs Sequent Scientific Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Albert David | 0.32% | -8.94% | -12.15% | 0.53% | -30.51% | -39.47% |
| Sequent Scientific | -3.97% | -0.34% | -9.41% | 8.30% | 7.32% | -9.00% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Albert David | -36.97% | 52.41% | 64.89% | 153.55% | 153.55% | 153.55% |
| Sequent Scientific | 22.29% | 57.12% | 26.68% | 13.98% | 13.98% | 13.98% |
Performance & Financial Health Analysis: Albert David vs Sequent Scientific
| Metric | ALBERTDAVD | SEQUENT |
|---|---|---|
| Market Information | ||
| Market Cap | ₹4.63B | ₹44.76B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 7,471 | 414,428 |
| 90 Day Avg. Volume | 7,851 | 471,488 |
| Last Close | ₹811.35 | ₹168.04 |
| 52 Week Range | ₹762.60 - ₹1,753.95 | ₹117.35 - ₹240.70 |
| % from 52W High | -53.74% | -30.19% |
| All-Time High | ₹1,753.95 (Sep 02, 2024) | ₹336.50 (Jun 28, 2021) |
| % from All-Time High | -53.74% | -50.06% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.21% | 0.11% |
| Quarterly Earnings Growth | -0.58% | 0.12% |
| Financial Health | ||
| Profit Margin (TTM) | 0.02% | 0.01% |
| Operating Margin (TTM) | -0.18% | 0.09% |
| Return on Equity (TTM) | 0.04% | 0.04% |
| Debt to Equity (MRQ) | 3.14 | 62.47 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹687.70 | ₹28.19 |
| Cash per Share (MRQ) | ₹426.93 | ₹2.52 |
| Operating Cash Flow (TTM) | ₹-111,139,000 | ₹833.62M |
| Levered Free Cash Flow (TTM) | ₹172.01M | ₹453.76M |
| Dividends | ||
| Last 12-Month Dividend Yield | 1.86% | N/A |
| Last 12-Month Dividend | ₹16.50 | ₹0.00 |
Valuation & Enterprise Metrics Analysis: Albert David vs Sequent Scientific
| Metric | ALBERTDAVD | SEQUENT |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 26.89 | 210.48 |
| Forward P/E | N/A | 35.43 |
| PEG Ratio | N/A | 35.43 |
| Price to Sales (TTM) | 1.42 | 2.89 |
| Price to Book (MRQ) | 1.18 | 6.35 |
| Market Capitalization | ||
| Market Capitalization | ₹4.63B | ₹44.76B |
| Enterprise Value | ₹2.30B | ₹48.00B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 0.70 | 3.09 |
| Enterprise to EBITDA | -23.37 | 30.33 |
| Risk & Other Metrics | ||
| Beta | 0.07 | 0.91 |
| Book Value per Share (MRQ) | ₹687.70 | ₹28.19 |
Financial Statements Comparison: Albert David vs Sequent Scientific
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | ALBERTDAVD | SEQUENT |
|---|---|---|
| Revenue/Sales | ₹748.93M | ₹4.02B |
| Cost of Goods Sold | ₹293.25M | ₹2.00B |
| Gross Profit | ₹455.68M | ₹2.02B |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹-65.60M | ₹294.80M |
| EBITDA | ₹-98.63M | ₹442.10M |
| Pre-Tax Income | ₹-118.09M | ₹163.10M |
| Income Tax | ₹-14.81M | ₹59.30M |
| Net Income (Profit) | ₹-103.28M | ₹103.80M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | ALBERTDAVD | SEQUENT |
|---|---|---|
| Cash & Equivalents | ₹4.17M | ₹626.60M |
| Total Current Assets | ₹3.54B | ₹8.74B |
| Total Current Liabilities | ₹1.04B | ₹5.05B |
| Long-Term Debt | ₹13.31M | ₹3.00B |
| Total Shareholders Equity | ₹3.92B | ₹7.70B |
| Retained Earnings | N/A | N/A |
| Property, Plant & Equipment | ₹977.12M | ₹2.84B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | ALBERTDAVD | SEQUENT |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | ALBERTDAVD | SEQUENT |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 7,471 | 414,428 |
| Average Daily Volume (90 Day) | 7,851 | 471,488 |
| Shares Outstanding | 5.71M | 249.89M |
| Float Shares | 2.05M | 117.77M |
| % Held by Insiders | 0.65% | 0.53% |
| % Held by Institutions | 0.02% | 0.13% |
Dividend Analysis & Yield Comparison: Albert David vs Sequent Scientific
| Metric | ALBERTDAVD | SEQUENT |
|---|---|---|
| Last 12-Month Dividend | ₹16.50 | ₹0.00 |
| Last 12-Month Dividend Yield | 1.86% | N/A |
| 3-Year Avg Annual Dividend | ₹17.50 | ₹0.00 |
| 3-Year Avg Dividend Yield | 1.16% | N/A |
| 3-Year Total Dividends | ₹52.50 | ₹0.00 |
| Ex-Dividend Date | Jul 25, 2025 | N/A |